GSK Supply Status
At this time, COVID-19 is not having an impact on GSK supply in the UK.
Please note: this page is updated weekly. If a product is not listed below, GSK are not experiencing supply constraints. Please contact your wholesaler
Product name |
PIP Code |
Status |
Estimated recovery date |
---|---|---|---|
AUGMENTIN TABLET 625MG 3X7_GB | 531012 | OUT OF STOCK | LATE APRIL 2024 |
AVAMYS ANS 27.5MCG 1X120D_XU-GSK | 3438587 | OUT OF STOCK | LATE APRIL 2024 |
BETNOVATE CRM 0.1% 100G UK-GSK | 29454 | OUT OF STOCK | LATE JUNE 2024 |
BETNOVATE CRM 0.1% 30G UK-GSK | 29447 | OUT OF STOCK | EARLY JULY 2024 |
BIOPSY PUNCH 2MM 10 | 8115842 | OUT OF STOCK | LATE JULY 2024 |
BIOPSY PUNCH 4MM 10 | 8115651 | OUT OF STOCK | LATE MAY 2024 |
EUMOVATE CRM 0.05% 30G UK-GSK | 143198 | OUT OF STOCK | LATE JUNE 2024 |
EUMOVATE OINT 0.05% 30G UK-GSK | 143214 | OUT OF STOCK | EARLY JULY 2024 |
FLIXOTIDE EVOHALER 125MCG X120D_GB | 2675528 | OUT OF STOCK | EARLY MAY 2024 |
FLIXOTIDE EVOHALER 250MCG X120D_GB | 2675544 | OUT OF STOCK | EARLY MAY 2024 |
IMIGRAN RADIS TABL 100MG 1X6 | 3054871 | OUT OF STOCK | TBC |
IMIGRAN RADIS TABL 50MG 1X6 | 3054855 | OUT OF STOCK | TBC |
IMIGRAN TABLET 100MG 1X6 | 109546 | OUT OF STOCK | TBC |
IMIGRAN TABLET 50MG 1X6 | 2095685 | OUT OF STOCK | TBC |
ZOVIRAX FD 500MGX5 CP UK | 489633 | OUT OF STOCK | EARLY MAY 2024 |
Product Name |
Pip code |
Status |
Estimated Recovery Date |
---|---|---|---|
RSV OA VIAL + AS01E VIAL AFS XU | 5401518 | OUT OF STOCK | TBC |
If you have any queries about the availability of a product, please contact your wholesaler.
3rd Party Distribution
From 1st Sept 2023, GSK and Recordati have agreed a deal whereby RECORDATI PHARMACEUTICALS LIMITED will take over the Distribution and Commercial activities for the following products.
Product name |
PIP Code |
---|---|
AVODART Capsules 0.5mg x 30 | 2921070 |
COMBODART Capsules 0.5mg/0.4mg x 30 | 3542560 |
Orders can be placed at this email address:
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com).
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.